NeuroOne Grabs FDA Clearance For Ablation Tech

December 13, 2023

GSK Licenses Shigella Vaccine Candidate to Bharat Biotech for Continued Development

June 17, 2025

McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology

August 29, 2024

Must Read

Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

September 30, 2025

Boryung acquires global rights to Sanofi’s Taxotere in $205M deal, aims to revive legacy chemotherapy drug

September 30, 2025

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

September 29, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

Moderna Reports Strong Immunological Response From Next-Generation COVID-19 Vaccine mNEXSPIKE Against Emerging Strain

Boryung acquires global rights to Sanofi’s Taxotere in $205M deal, aims to revive legacy chemotherapy drug

Bristol Myers Squibb to Launch Schizophrenia Drug Cobenfy in UK at US Price

Pfizer agrees to a $4.9 billion upfront purchase of Metsera to strengthen obesity portfolio

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Tag: Cusatuzumab

Cusatuzumab back in Argenx’s court as Janssen’s Cilag discontinues partnership

Editor Picks

NeuroOne Grabs FDA Clearance For Ablation Tech

GSK Licenses Shigella Vaccine Candidate to Bharat Biotech for Continued Development

McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology

Must Read

Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

Boryung acquires global rights to Sanofi’s Taxotere in $205M deal, aims to revive legacy chemotherapy drug

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

Hot Topics

About Us

Follow Us